Genetic Recombination of the <i>rpoB</i> Gene as a Mechanism of the <i>Mycobacterium tuberculosis </i>Resistance to Rifampin


  • Levani Lomidze
  • Mamuka Kotetishvili Faculty of Natural Sciences and Engineering, Ilia State University, Tbilisi


Mycobacterium tuberculosis, resistance to rifampin, genetic recombination


The molecular genetic mechanisms whereby Mycobacterim tuberculosis develops resistance to rifampin (RIF) are poorly understood.  Using the tests for selection and genetic recombination, we analyzed rpoB loci of the M. tuberculosis strains harboring the synonymous single nucleotide polymorphisms (sSNPs) to detect the horizontal gene transfer (HGT) of this genetic locus.  The rpoB codons GGC507, GGG534, GGC556 and GGG566 were revealed to be the hotspots for the multiple sSNPs.  The strains carrying multiple nucleotide polymorphisms across these codons were from either Iran or the Republic of Belarus, exhibiting regional patterns of the rpoB sSNPs distribution.  The dN/dS ratios were ≤0.7363 for the rpoB loci that harbored these sSNPs, showing no significant selective pressures on the amino acid changes. The Index of Association (IA) being 1.110, for the DNA substitutions of the rpoB loci with the sSNPs, revealed that this genetic locus is not clonal in M. tuberculosis. Moreover, the splitstree analysis resulted in the parallelograms with the strong fit and bootstrap values (95-100 and 85-100 respectively), exhibiting the HGT events in some of these rpoB loci.  Thus, it is strongly suggested that the HGT of rpoB of M. tuberculosis contributes to the generation of this species resistance to RIF.


Herrera L, Jiménez S, Valverde A, García-Aranda MA, Sáez-Nieto JA. 2003. Molecular analysis of rifampicin-resistant Mycobacterium tuberculosis isolated in Spain (1996-2001). Description of new mutations in the rpoB gene and review of the literature. Int J Antimicrob Agents 21(5): 403-8.

Raviglione MC, Snider DE Jr, Kochi A. 1995. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic. JAMA 273(3):220-6.

Velayati AA, Masjedi MR, Farnia P, Tabarsi P, Ghanavi J, Ziazarifi AH, Hoffner SE. 2009. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in iran. Chest 136(2):420-5.

Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, van Soolingen D, Jensen P, Bayona J. 2010. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis. Lancet 375(9728):1830-43.

David HL. 1970. Probability distribution of drug-resistant mutants in unselected populations of Mycobacterium tuberculosis. Applied microbiology 20:810–814.

Ford CB, Lin PL, Chase MR, Shah RR, Iartchouk O, Galagan J, Mohaideen N, Ioerger TR, Sacchettini JC, Lipsitch M, Flynn JL, Fortune SM. 2011. Use of whole genome sequencing to estimate the mutation rate of Mycobacterium tuberculosis during latent infection. Nat Genet 43(5):482-6.

Ford CB, Shah RR, Maeda MK, Gagneux S, Murray MB, Cohen T, Johnston JC, Gardy J, Lipsitch M, Fortune SM. 2013. Mycobacterium tuberculosis mutation rate estimates from different lineages predict substantial differences in the emergence of drug-resistant tuberculosis. Nat Genet 45(7):784-90.

Migliori GB, De Iaco G, Besozzi G, Centis R, Cirillo DM. 2007. First tuberculosis cases in Italy resistant to all tested drugs. Euro Surveill 12:E070517.1.

Pablos-Mendez A, Knirsch CA, Barr RG, Lerner BH, Frieden TR. 1997. Nonadherence in tuberculosis treatment: predictors and consequences in New York City. Am J Med 102:164–170.

Udwadia ZF, Pinto LM, Uplekar MW. 2010. Tuberculosis management by private practitioners in Mumbai, India: has anything changed in two decades? PLoS ONE 5:e12023.

Johnson R, Warren RM, van der Spuy GD, Gey van Pittius NC, Theron D, Streicher EM, Bosman M, Coetzee GJ, van Helden PD, Victor TC. 2010. Drug-resistant tuberculosis epidemic in the Western Cape driven by a virulent Beijing genotype strain. Int J Tuberc Lung Dis 14(1):119-21.

Streicher EM, Warren RM, Kewley C, Simpson J, Rastogi N, Sola C, van der Spuy GD, van Helden PD, Victor TC. 2004. Genotypic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates from rural districts of the Western Cape Province of South Africa. J Clin Microbiol 42(2):891-4.

Heep M, Brandstätter B, Rieger U, Lehn N, Richter E, Rüsch-Gerdes S, Niemann S. 2001. Frequency of rpoB mutations inside and outside the cluster I region in rifampin-resistant clinical Mycobacterium tuberculosis isolates. J Clin Microbiol 39(1):107-10.

Ramaswamy S, Musser JM. 1998. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis 79(1):3-29. Review.

Telenti, A, Imboden P, Marchesi F, Lowrie D, Cole S, Colston MJ, Matter L, Schopfer K, and Bodmer T. 1993. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis. Lancet 341:647–650.

Musser JM. 1995. Antimicrobial agent resistance in mycobacteria: molecular genetic insights. Clin Microbiol Rev 8(4):496-514. Review.

Miller LP, Crawford JT, Shinnick TM. 1994. The rpoB gene of Mycobacterium tuberculosis. Antimicrob Agents Chemother 38(4):805-11.

Heep M, Rieger U, Beck D, Lehn N. 2000. Mutations in the beginning of the rpoB gene can induce resistance to rifamycins in both Helicobacter pylori and Mycobacterium tuberculosis. Antimicrob Agents Chemother 44(4):1075-7.

Schmalstieg AM, Srivastava S, Belkaya S, Deshpande D, Meek C, Leff R, van Oers NS, Gumbo T. 2012. The antibiotic resistance arrow of time: efflux pump induction is a general first step in the evolution of mycobacterial drug resistance. Antimicrob Agents Chemother 56(9):4806-15.

Louw GE, Warren RM, Gey van Pittius NC, Leon R, Jimenez A, Hernandez-Pando R, McEvoy CR, Grobbelaar M, Murray M, van Helden PD, Victor TC. 2011. Rifampicin reduces susceptibility to ofloxacin in rifampicin-resistant Mycobacterium tuberculosis through efflux. Am J Respir Crit Care Med. 184(2):269-76.

Adams KN, Takaki K, Connolly LE, Wiedenhoft H, Winglee K, Humbert O, Edelstein PH, Cosma CL, Ramakrishnan L. 2011. Drug tolerance in replicating mycobacteria mediated by a macrophage-induced efflux mechanism. Cell 145(1):39-53.

Eldholm V, Norheim G, von der Lippe B, Kinander W, Dahle UR, Caugant DA, Mannsåker T, Mengshoel AT, Dyrhol-Riise AM, Balloux F. 2014. Evolution of extensively drug-resistant Mycobacterium tuberculosis from a susceptible ancestor in a single patient. Genome Biol 15(11):490.

Baker L, Brown T, Maiden MC, Drobniewski F. 2004. Silent nucleotide polymorphisms and a phylogeny for Mycobacterium tuberculosis. Emerg Infect Dis. 10(9):1568-77.

Smith NH, Dale J, Inwald J, Palmer S, Gordon SV, Hewinson RG, Smith JM. 2003. The population structure of Mycobacterium bovis in Great Britain: clonal expansion. Proc Natl Acad Sci U S A 100(25):15271-5.

Krzywinska E, Krzywinski J, Schorey JS. 2004. Naturally occurring horizontal gene transfer and homologous recombination in Mycobacterium. Microbiology 150(Pt 6):1707-12.

Camacho C, Coulouris G, Avagyan V, Ma N, Papadopoulos J, Bealer K, Madden TL. 2009. BLAST+: architecture and applications. BMC Bioinformatics 10:421.

Jeanmougin F, Thompson J. D, Gouy M, Higgins DG, and Gibson TJ. 1998. Multiple sequence alignment with Clustal X. Trends Biochem Sci 23:403–405.

Nei M, Gojobori T. 1986. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol 3(5):418-26.

Smith JM, Smith NH, O'Rourke M, Spratt BG. 1993. How clonal are bacteria? Proc Natl Acad Sci U S A 15;90(10):4384-8.

Bandelt HJ, Dress AW. 1992. Split decomposition: a new and useful approach to phylogenetic analysis of distance data. Mol Phylogenet Evol 1(3):242-52.

Huson DH, Bryant D. 2006. Application of phylogenetic networks in evolutionary studies. Mol Biol Evol 23(2):254-67.

Lau PC, Forghani F, Labbé D, Bergeron H, Brousseau R, Höltke HJ. 1994. The NlaIV restriction and modification genes of Neisseria lactamica are flanked by leucine biosynthesis genes. Mol Gen Genet 243(1):24-31.

Nagano Y, Walker J, Loughrey A, Millar C, Goldsmith C, Rooney P, Elborn S, Moore J. 2009. Identification of airborne bacterial and fungal species in the clinical microbiology laboratory of a university teaching hospital employing ribosomal DNA (rDNA) PCR and gene sequencing techniques. Int J Environ Health Res 19(3):187-99.

Blanc G, Mozar M, Agarkova IV, Gurnon JR, Yanai-Balser G, Rowe JM, Xia Y, Riethoven JJ, Dunigan DD, Van Etten JL. 2014. Deep RNA sequencing reveals hidden features and dynamics of early gene transcription in Paramecium bursaria chlorella virus 1. PLoS One 7;9(3).

Strouts FR, Power P, Croucher NJ, Corton N, van Tonder A, Quail MA, Langford PR, Hudson MJ, Parkhill J, Kroll JS, Bentley SD. 2012. Lineage-specific virulence determinants of Haemophilus influenzae biogroup aegyptius. Emerg Infect Dis 18(3):449-57.

Gibson A, Brown T, Baker L, Drobniewski F. 2005. Can 15-locus mycobacterial interspersed repetitive unit-variable-number tandem repeat analysis provide insight into the evolution of Mycobacterium tuberculosis? Appl Environ Microbiol 71(12):8207-13.

O'Sullivan DM, McHugh TD, Gillespie SH. 2005. Analysis of rpoB and pncA mutations in the published literature: an insight into the role of oxidative stress in Mycobacterium tuberculosis evolution? J Antimicrob Chemother 55(5):674-9.

Miyoshi-Akiyama T, Satou K, Kato M, Shiroma A, Matsumura K, Tamotsu H, Iwai H, Teruya K, Funatogawa K, Hirano T, Kirikae T. 2015. Complete annotated genome sequence of Mycobacterium tuberculosis (Zopf) Lehmann and Neumann (ATCC35812) (Kurono). Tuberculosis (Edinb). 95(1):37-9. doi: 10.1016/

Norberg P, Kasubi MJ, Haarr L, Bergström T, Liljeqvist JA. 2007. Divergence and recombination of clinical herpes simplex virus type 2 isolates. J Virol 81(23):13158-67.

Kotetishvili M, Stine OC, Kreger A, Morris JG Jr, Sulakvelidze A. 2002. Multilocus sequence typing for characterization of clinical and environmental salmonella strains. J Clin Microbiol 40(5):1626-35.

Kotetishvili M, Stine OC, Chen Y, Kreger A, Sulakvelidze A, Sozhamannan S, Morris JG Jr. 2003. Multilocus sequence typing has better discriminatory ability for typing Vibrio cholerae than does pulsed-field gel electrophoresis and provides a measure of phylogenetic relatedness. J Clin Microbiol 41(5):2191-6.

Revazishvili T, Kotetishvili M, Stine OC, Kreger AS, Morris JG Jr, Sulakvelidze A. 2004. Comparative analysis of multilocus sequence typing and pulsed-field gel electrophoresis for characterizing Listeria monocytogenes strains isolated from environmental and clinical sources. J Clin Microbiol 42(1):276-85.

Kotetishvili M, Kreger A, Wauters G, Morris JG Jr, Sulakvelidze A, Stine OC. 2005. Multilocus sequence typing for studying genetic relationships among Yersinia species. J Clin Microbiol 43(6):2674-84.

Stalder U, Stephan R, Corti S, Bludau M, Maeschli A, Klocke P, Johler S. 2014. Short communication: Staphylococcus aureus isolated from colostrum of dairy heifers represent a closely related group exhibiting highly homogeneous genomic and antimicrobial resistance features. J Dairy Sci 97(8):4997-5000.

Qian L, Abe C, Lin TP, Yu MC, Cho SN, Wang S, Douglas JT. 2002. rpoB genotypes of Mycobacterium tuberculosis Beijing family isolates from East Asian countries. J Clin Microbiol 40(3):1091-4.

Glynn JR, Whiteley J, Bifani PJ, Kremer K, Van Soolingen D. 2002. Worldwide occurrence of Beijing/W strains of Mycobacterium tuberculosis: a systematic review. Emerging Infect Dis 8:843–849.

Drobniewski F, Balabanova Y, Nikolayevsky V, Ruddy M, Kuznetzov S, Zakharova S, Melentyev A, Fedorin I. 2005. Drug-resistant tuberculosis, clinical virulence, and the dominance of the Beijing strain family in Russia. JAMA 293(22):2726-31.

Coscolla M, Gagneux S. Does. 2010. M. tuberculosis genomic diversity explain disease diversity? Drug Discovery Today: Disease Mechanisms 7:e43–e59.

European Concerted Action on New Generation Genetic Markers and Techniques for the Epidemiology and Control of Tuberculosis. 2006. Beijing/W genotype Mycobacterium tuberculosis and drug resistance. Emerging Infect Dis 12:736–743.

Pang Y, Zhou Y, Zhao B, Liu G, Jiang G, Xia H, Song Y, Shang Y, Wang S, Zhao YL. 2012. Spoligotyping and drug resistance analysis of Mycobacterium tuberculosis strains from national survey in China. PLoS One 7(3):e32976.

Braden, C. R., G. P. Morlock, C. L. Woodley, K. R. Johnson, A. C. Colombel, M. D. Cave, Z. Yang, S. E. Valway, I. M. Onorato, and J. T. Crawford 2001. Simultaneous infection with multiple strains of Mycobacterium tuberculosis. Clin. Infect. Dis 33:e42–e47.

Chaves, F, Dronda F, Alonso-Sanz M, and Noriega AR. 1999. Evidence of exogenous reinfection and mixed infection with more than one strain of Mycobacterium tuberculosis among Spanish HIV-infected inmates. AIDS 13:615–620.

Warren RM, Victor TC, Streicher EM, Richardson M, Beyers N, van Pittius NC, and van Helden PD. 2004. Patients with active tuberculosis often had different strains in the same sputum specimen. Am. J. Respir. Crit. Care Med 169:610–614.

Yeh RW, Hopewell PC, and Daley CL. 1999. Simultaneous infection with two strains of Mycobacterium tuberculosis identified by restriction fragment length polymorphism analysis. Int. J. Tuberc. Lung Dis 3:537–539.

Titov LP, Zakerbostanabad S, Slizen V, Surkova L, Taghikhani M, Bahrmand A. 2006. Molecular characterization of rpoB gene mutations in rifampicine-resistant Mycobacterium tuberculosis isolates from tuberculosis patients in Belarus. Biotechnol J 12:1447-52.




How to Cite

Lomidze, L., & Kotetishvili, M. (2015). Genetic Recombination of the <i>rpoB</i> Gene as a Mechanism of the <i>Mycobacterium tuberculosis </i>Resistance to Rifampin. Asian Journal of Pharmacy, Nursing and Medical Sciences, 3(2). Retrieved from